TOOKAD prostate cancer treatment

A globally praised prostate cancer treatment was developed in Israel; an ultrasound machine for treating tremors is produced by Israel’s Insightec; Tel Aviv University researchers discovered that a popular food supplement can reverse the effects of a debilitating neurodegenerative disorder, and much more.

By: Michael Ordman


BBC finally admits prostate cancer treatment is Israeli

BBC Radio 4’s Today Program omitted the fact (as newsletter readers know) that the TOOKAD prostate cancer treatment, praised globally, was developed at Israel’s Weizmann Institute.  After protests, BBC News interviewed co-developer Professor Avigdor Scherz.

Treatment for tremors is also Israeli

Yet another example. The BBC radio broadcast itself didn’t mention that the Exablate Neuro ultrasound machine for treating tremor is produced by Israel’s Insightec.  They then buried that fact deep in their report on their website.

Food supplement can treat FD disorder

Tel Aviv University researchers have discovered that a popular food supplement called phosphatidylserine can reverse the effects of the debilitating neurodegenerative disorder Familial Dysautonomia (FD).  It improves the supply route to neurons by reducing levels of enzyme HDAC6.

Life-saving treatments from Kamada

Amir London, CEO of Israeli biotech Kamada, was interviewed on ILTV Daily about Kamada’s protein purification treatments for lung disease and rabies.  Kamada’s Glassia is also being tested for treating Type 1 diabetes, GVHD and the rejection of bone marrow and lung transplants.

First Kidney Dialysis for Sierra Leone

In 2012, MASHAV – Israel Foreign Ministry’s agency for international development cooperation donated the first-ever dialysis unit to Sierra Leone.  Due to the Ebola outbreak, the African country’s first dialysis treatment took place on Dec 15 this year, and a life was saved.

Dual action treatment for aggressive breast cancer

Scientists at Israel’s Weizmann Institute have made a breakthrough in treating triple negative breast cancer. This cancer lacks three receptors that serve as targets for anti-cancer drugs. However, inhibiting molecules EGFR and PYK2 significantly reduces the size of tumors.

Blood warmer prevents hypothermia

Two thirds of sufferers of blood loss trauma experience hypothermia.  Blood and fluids used in transfusions must be warmed from storage temperatures (4 degrees C) to body heat (37 degrees C). Israeli startup QinFlow’s Warrior portable system does just that – faster than any alternative system.  It recently received US FDA approval.

Needle-free scar remover

Israel’s PerfAction Technologies has developed EnerJet (Airgent in the US) – a non-thermal, no-needle, high-pressure jet stream to introduce any kind of healing agent or skin-enhancement material. It removes acne scars, surgical scars etc.  Available in 22 countries including Indonesia and Malaysia.


Click HERE for this week’s Good News from Israel

Source: United with Israel